Not of Standard Quality Drug Prosecution: Sampling, the Government Analyst and the Right to Re-Test
A not of standard quality drug prosecution begins with a small thing: an Inspector takes a sample from a batch. Months later a report arrives, and with it a criminal complaint agai
Drugs and Cosmetics Act 1940 to 2025: Compounding Rules, Decriminalisation & Enforcement Shift in India
ABSTRACT The Drugs and Cosmetics Act, 1940 was enacted with a clearly deterrent purpose: to protect the Indian public from substandard and spurious drugs by imposing criminal liabi
CDSCO’s Dual Role as Regulator and Prosecutor: Structural Conflict of Interest and Reform Proposals
ABSTRACT The Central Drugs Standard Control Organisation (CDSCO) occupies an unusual institutional position in India’s regulatory landscape: it is simultaneously the authorit
Strict Liability Offences Under the Drugs and Cosmetics Act, 1940: Are India’s Courts Adequately Enforcing Them?
ABSTRACT The Drugs and Cosmetics Act, 1940 creates strict liability offences for the manufacture and sale of not-of-standard-quality (NSQ) drugs. Parliament deliberately excluded t
Section 33P of the Drugs and Cosmetics Act: India’s Unused Instrument for Uniform Drug Law Enforcement
ABSTRACT Section 33P of the Drugs and Cosmetics Act, 1940 empowers the Central Government to give binding directions to State Governments for carrying into execution any provision
Compounding of Offences Under the Drugs and Cosmetics Act: The 2025 Rules and Their Interface with Prosecution
ABSTRACT The Drugs and Cosmetics (Compounding of Offences) Rules, 2025, notified on April 24, 2025 under Sections 32B and 33(2)(r) of the Drugs and Cosmetics Act, 1940, represent a
Can CDSCO Ignore Its Own Prosecution Guidelines? Legal Validity and Article 14 Challenge Explained
ABSTRACT The DCC and CDSCO prosecution guidelines are not legally binding as a matter of positive law — they cannot override the strict liability provisions of the Drugs and Cosm
Section 26A of the Drugs and Cosmetics Act, 1940: India’s Sharpest Drug Regulatory Instrument
ABSTRACT Section 26A of the Drugs and Cosmetics Act, 1940 empowers the Central Government to prohibit the manufacture, sale, or distribution of any drug in the public interest by n
CDSCO India: Drug Approval Process, Licensing & Compliance Framework
Introduction to CDSCO The pharmaceutical industry in India is a complex and rapidly evolving sector, playing a crucial role in global healthcare. At the heart of regulating this va
Section 52A of the NDPS Act: A Critical Analysis
Introduction Section 52A of the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, introduced via amendment in 1989, addresses a crucial aspect of drug law enforcement &#
Whatsapp
